Factor XI Inhibitors: A New Horizon in Anticoagulation Therapy
Abstract Anticoagulation therapy has undergone significant evolution, marked by the emergence of direct oral anticoagulants with distinct advantages.Despite these advancements, challenges persist in managing residual thrombotic and bleeding risks, particularly among vulnerable populations.The pursuit of alternative drugs has honed in on factor XI/X